Literature DB >> 16855615

Magnetic resonance imaging of viral particle biodistribution in vivo.

J K Räty1, T Liimatainen, T Wirth, K J Airenne, T O Ihalainen, T Huhtala, E Hamerlynck, M Vihinen-Ranta, A Närvänen, S Ylä-Herttuala, J M Hakumäki.   

Abstract

We describe here a technique for the visualization of viral vector delivery by magnetic resonance imaging (MRI) in vivo. By conjugating avidin-coated baculoviral vectors (Baavi) with biotinylated ultra-small superparamagnetic iron oxide particles (USPIO), we are able to produce vector-related MRI contrast in the choroid plexus cells of rat brain in vivo over a period of 14 days. Ten microlitres of 2.5 x 10(10) PFU/ml nuclear-targeted LacZ-encoding Baavi with bUSPIO coating was injected into rat brain ventricles and visualized by MRI at 4.7 T. As baculoviruses exhibit restricted cell-type specificity in the rat brain, altered MRI contrast was detected in the choroid plexus of the injected ventricles. No specific signal loss was detected when wild-type baculoviruses or intact biotinylated USPIO particles were injected into the lateral ventricles. Cryosectioned brains were stained for nuclear-targeted beta-galactosidase gene expression, which was found to colocalize with MRI contrast. This study provides the first proof of principle for robust and non-invasive viral vector MRI by using avidin-displaying viruses in vivo. Considering the widespread use of MRI in current medical imaging, the approach is likely to provide numerous future applications in imaging of therapeutic gene transfer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16855615     DOI: 10.1038/sj.gt.3302828

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  16 in total

Review 1.  Non-invasive genetic imaging for molecular and cell therapies of cancer.

Authors:  C Belmar; P-W So; G Vassaux; V Moleiro-Sanemeterio; P Martín-Duque
Journal:  Clin Transl Oncol       Date:  2007-11       Impact factor: 3.405

Review 2.  Hybrid nanoparticles for detection and treatment of cancer.

Authors:  Michael J Sailor; Ji-Ho Park
Journal:  Adv Mater       Date:  2012-05-21       Impact factor: 30.849

Review 3.  Enabling individualized therapy through nanotechnology.

Authors:  Jason H Sakamoto; Anne L van de Ven; Biana Godin; Elvin Blanco; Rita E Serda; Alessandro Grattoni; Arturas Ziemys; Ali Bouamrani; Tony Hu; Shivakumar I Ranganathan; Enrica De Rosa; Jonathan O Martinez; Christine A Smid; Rachel M Buchanan; Sei-Young Lee; Srimeenakshi Srinivasan; Matthew Landry; Anne Meyn; Ennio Tasciotti; Xuewu Liu; Paolo Decuzzi; Mauro Ferrari
Journal:  Pharmacol Res       Date:  2010-01-05       Impact factor: 7.658

4.  In vivo fluorescence imaging is well-suited for the monitoring of adenovirus directed transgene expression in living organisms.

Authors:  Sevim Kahraman; Ercument Dirice; Ahter Dilsad Sanlioglu; Burcak Yoldas; Huseyin Bagci; Metin Erkilic; Thomas S Griffith; Salih Sanlioglu
Journal:  Mol Imaging Biol       Date:  2009-09-30       Impact factor: 3.488

Review 5.  The application of nanoparticles in gene therapy and magnetic resonance imaging.

Authors:  Fernando Herranz; Elena Almarza; Ignacio Rodríguez; Beatriz Salinas; Yamilka Rosell; Manuel Desco; Jeff W Bulte; Jesús Ruiz-Cabello
Journal:  Microsc Res Tech       Date:  2011-04-11       Impact factor: 2.769

6.  Superparamagnetic iron oxide nanoparticles: promises for diagnosis and treatment of cancer.

Authors:  Sophie Laurent; Morteza Mahmoudi
Journal:  Int J Mol Epidemiol Genet       Date:  2011-11-25

7.  Polymeric PARACEST MRI contrast agents as potential reporters for gene therapy.

Authors:  Yunkou Wu; Christiane E Carney; Michael Denton; Elaine Hart; Piyu Zhao; Daniel N Streblow; A Dean Sherry; Mark Woods
Journal:  Org Biomol Chem       Date:  2010-09-16       Impact factor: 3.876

8.  Toxicological Aspects of Iron Oxide Nanoparticles.

Authors:  Natalia Fernández-Bertólez; Carla Costa; Fátima Brandão; João Paulo Teixeira; Eduardo Pásaro; Vanessa Valdiglesias; Blanca Laffon
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

9.  Endocytic uptake pathways utilized by CPMV nanoparticles.

Authors:  Emily M Plummer; Marianne Manchester
Journal:  Mol Pharm       Date:  2012-09-20       Impact factor: 4.939

10.  Viral nanoparticles associate with regions of inflammation and blood brain barrier disruption during CNS infection.

Authors:  Leah P Shriver; Kristopher J Koudelka; Marianne Manchester
Journal:  J Neuroimmunol       Date:  2009-04-25       Impact factor: 3.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.